Abstract PS1-08-08: monarchE: subgroup analysis of adjuvant abemaciclib + endocrine therapy for HR+, HER2-, high-risk early breast cancer by nodal status
Authors
J. Cortés
Susana Morales
Sasha Amdur
M. Henriques Abreu
O. Ozyilkan
S. M. Tolaney
K. Maia Vianna
H. S. Rugo
M. P. Goetz
B. R Grimes
H. Kalofonos
B. San Antonio
S. R. D. Johnston
J. Sohn
M. Munoz
A. Chan
P. Neven
H. Melgaard Nielsen
M. Martín
Institutions
Brigham and Women's Hospital (US)
Ankara University (TR)
Eli Lilly (United States) (US)
Universitair Ziekenhuis Leuven (BE)
Government of Western Australia Department of Health (AU)
General University Hospital of Patras (GR)
Hospital Universitari Arnau de Vilanova (ES)
Aarhus University Hospital (DK)
Hospital General Universitario Gregorio Marañón (ES)
National Cancer Center (US)
Instituto Português de Oncologia Francisco Gentil (PT)
Abstract PS1-08-08: monarchE: subgroup analysis of adjuvant abemaciclib + endocrine therapy for HR+, HER2-, high-risk early breast cancer by nodal status
J. Cortés, Susana Morales, Sasha Amdur, M. Henriques Abreu et al.
Journal
Clinical Cancer Research
Topics
Advanced Breast Cancer Therapies
article
Abstract PS1-08-08: monarchE: subgroup analysis of adjuvant abemaciclib + endocrine therapy for HR+, HER2-, high-risk early breast cancer by nodal status
J. Cortés, Susana Morales, Sasha Amdur, M. Henriques Abreu, O. Ozyilkan, S. M. Tolaney, K. Maia Vianna, H. S. Rugo, M. P. Goetz, B. R Grimes, H. Kalofonos, B. San Antonio, S. R. D. Johnston, J. Sohn, M. Munoz, A. Chan, P. Neven, H. Melgaard Nielsen, M. Martín
article en
Abstract
No abstract available for this paper.
Publication Tag
Clinical Cancer ResearchVol. 32(4_Supplement)
Institutions
Brigham and Women's Hospital (US), Ankara University (TR), Eli Lilly (United States) (US), Universitair Ziekenhuis Leuven (BE), Government of Western Australia Department of Health (AU), General University Hospital of Patras (GR), Hospital Universitari Arnau de Vilanova (ES), Aarhus University Hospital (DK), Hospital General Universitario Gregorio Marañón (ES), National Cancer Center (US), Instituto Português de Oncologia Francisco Gentil (PT), City of Hope (US), Hospital Quirónsalud Barcelona (ES), Dana-Farber Cancer Institute (US), Royal Marsden Hospital (GB), Mayo Clinic in Arizona (US), Instituto de Oncologia do Paraná (BR), Praxis für Hämatologie und Onkologie (DE), International Breast Cancer Study Group (CH), Dana-Farber Brigham Cancer Center (US)